Literature DB >> 25602127

Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids.

Zoe Giotaki1, Athanasios Fountas, Theodora Tsirouki, Alexandra Bargiota, Stelios Tigas, Agathocles Tsatsoulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25602127     DOI： 10.1089/thy.2014.0533

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  6 in total

Review 1.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

2.  Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency.

Authors:  Sofie Jespersen; Birte Nygaard; Lars Østergaard Kristensen
Journal:  Eur Thyroid J       Date:  2015-10-27

3.  Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.

Authors:  Diego Strianese; Francesca Rossi
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

Review 4.  Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.

Authors:  Katarzyna Pelewicz; Piotr Miśkiewicz
Journal:  Diagnostics (Basel)       Date:  2021-04-20

5.  Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves' ophthalmopathy.

Authors:  Jae Yeon Kim; Sohae Park; Hyun-Jung Lee; Helen Lew; Gi Jin Kim
Journal:  Stem Cell Res Ther       Date:  2020-11-05       Impact factor: 6.832

Review 6.  What we have to know about corticosteroids use during Sars-Cov-2 infection.

Authors:  F Ferraù; F Ceccato; S Cannavò; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.